pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,039 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT786Endpoints593BioPharma Dive228onclive165BioSpace63Fierce Biotech63raps25
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • <![CDATA[Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate Cancer]]>
    <![CDATA[Mark Garzotto, MD, discusses efficacy data with aglatimagene besadenovec plus valacyclovir and EBRT in localized prostate cancer.]]>
    onclive · 2mo ago↗ source
  • STAT+: FDA leadership shakeup widens following Makary’s departure
    The acting director of the FDA’s drug center, Tracy Beth Høeg, is leaving the agency. The news come days after Commissioner Marty Makary handed in his resignation.
    STAT · 2mo ago↗ source
  • <![CDATA[Dr Cirstea on Sequencing Considerations in R/R Multiple Myeloma]]>
    <![CDATA[Diana Cirstea, MD, discusses sequencing considerations in relapsed/refractory multiple myeloma in the era of T-cell–redirecting therapies.]]>
← prev
page 26 of 42
next →
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
onclive · 2mo ago
↗ source
  • <![CDATA[Dr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBC]]>
    <![CDATA[Jason Hafron, MD, discusses the significance of the FDA approval of adjuvant atezolizumab for MRD+ muscle-invasive bladder cancer.]]>
    onclive · 2mo ago↗ source
  • <![CDATA[Durvalumab Plus BCG Reduces High-Risk NMIBC Recurrence or Death Risk by 32% in Phase 3 POTOMAC Trial]]>
    <![CDATA[Durvalumab plus BCG induction and maintenance yielded an HR of 0.68 vs BCG alone for DFS in BCG-naive, high-risk non–muscle-invasive bladder cancer.]]>
    onclive · 2mo ago↗ source
  • <![CDATA[Darolutamide Plus ADT Yields Significant OS Benefit in mHSPC]]>
    <![CDATA[Darolutamide plus ADT demonstrated a 50% reduction in the risk of death in metastatic hormone-sensitive prostate cancer.]]>
    onclive · 2mo ago↗ source
  • <![CDATA[OncLive Weekly News Quiz (5/15/2026): Did You Catch 3 New FDA Oncology Approvals?]]>
    <![CDATA[Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.]]>
    onclive · 2mo ago↗ source
  • <![CDATA[Pembrolizumab Plus BCG Elicits 92% CR Rate in BCG-Naive Very High-Risk T1 NMIBC]]>
    <![CDATA[Pembrolizumab plus BCG achieved a 92% 6-month complete response rate in very high-risk T1 bladder cancer with no progression to muscle-invasive disease.]]>
    onclive · 2mo ago↗ source
  • STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
    Takeda Pharmaceuticals agreed to pay $13.6 million to settle allegations that it paid kickbacks to doctors to prescribe an antidepressant.
    STAT · 2mo ago↗ source
  • <![CDATA[FDA Approves Adjuvant Atezolizumab for MRD+ Muscle-Invasive Bladder Cancer]]>
    <![CDATA[The FDA approved adjuvant atezolizumab for muscle-invasive bladder cancer with circulating tumor DNA molecular residual disease.]]>
    onclive · 2mo ago↗ source
  • <![CDATA[Detalimogene Voraplasmid Yields 54% CR Rate in Heavily Pretreated BCG-Unresponsive NMIBC With CIS]]>
    <![CDATA[TRAEs were generally reversible and low grade, and 96.8% of patients remained free from progression to T2 or greater disease at the data cutoff. ]]>
    onclive · 2mo ago↗ source
  • <![CDATA[Roswell Park Team Members Take Part in Global Conference Dedicated to Indigenous Peoples and Cancer]]>
    <![CDATA[Members of Roswell Park Comprehensive Cancer Center participated in the 2026 World Indigenous Cancer Conference.]]>
    onclive · 2mo ago↗ source
  • STAT+: Up and down the ladder: The latest comings and goings
    From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
    STAT · 2mo ago↗ source
  • Opinion: First hantavirus, now Ebola: What two outbreaks reveal about global preparedness
    “Preparedness is not built during a crisis press conference or after a pathogen has already crossed borders,” writes Krutika Kuppalli.
    STAT · 2mo ago↗ source
  • <![CDATA[Poll Findings Highlight the Most Anticipated GU Cancer Abstracts at ASCO 2026]]>
    <![CDATA[GU experts identified key abstracts of interest from the upcoming ASCO Annual Meeting via OncLive’s social media.]]>
    onclive · 2mo ago↗ source
  • A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recorded
    A new Ebola outbreak has been confirmed in Congo’s remote Ituri province, with 246 suspected cases and 65 deaths recorded so far.
    STAT · 2mo ago↗ source
  • STAT+: A political contest in the U.K. could shake up drug pricing
    Makary and Cassidy's fates, U.S. pressures Germany to pay more for drugs, and other health news
    STAT · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
    In today's Pharmalittle roundup: U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and much more.
    STAT · 2mo ago↗ source
  • Opinion: Telehealth abortion with mifepristone continues, with backup plans still in place
    Restricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.
    STAT · 2mo ago↗ source
  • Mail-order abortion pills are legal (for now)
    Africa CDC declares Ebola outbreak in DRC, the violent fallout from Trump’s cuts to foreign aid, and more health news
    STAT · 2mo ago↗ source
  • <![CDATA[OncLive Polls Reveal Picks for Top GI Cancer Abstracts, Areas of Interest at ASCO 2026]]>
    <![CDATA[Polls highlighted key abstracts of interest from the upcoming ASCO Annual Meeting.]]>
    onclive · 2mo ago↗ source
  • <![CDATA[Prevention and Personalization Drive the Future of Oncodermatology in Melanoma ]]>
    <![CDATA[Beth McLellan, MD, discusses radiation dermatitis prevention, scalp cooling equity, and the future of personalized oncodermatology in melanoma management.]]>
    onclive · 2mo ago↗ source
  • Opinion: I’m 73. I wish my pills wouldn’t keep changing colors and shapes
    Pharmaceutical companies, generic manufacturers, and pharmacists should be more careful about changing how pills look.
    STAT · 2mo ago↗ source
  • Why isn’t alcohol seen as a public health emergency?
    Why isn't alcohol seen as a public health emergency? Alex Hogan talks to STAT's Isabella Cueto and Lev Facher about their new series on this week's STATus Report.
    STAT · 2mo ago↗ source
  • Opinion: Tributes to Craig Venter and the genomics race are missing something important
    A race, two rivals, a photo finish? Former National Human Genome Research Institute archivist explains what Craig Venter tributes are missing.
    STAT · 2mo ago↗ source